A world-first discovery from Australian researchers unlocks the potential for the development of better vaccines and therapies against influenza viruses tailored to different age groups.
The paper, published in Nature Immunology on Tuesday, has revealed special immune cells called “killer T cells” in older adults closely resemble those found in newborns and children.